低镁血症
维生素D缺乏
医学
内科学
维生素D与神经学
2019年冠状病毒病(COVID-19)
优势比
缺镁(植物)
胃肠病学
肌痛
儿科
疾病
镁
化学
有机化学
传染病(医学专业)
作者
Fernando Guerrero‐Romero,Claudia I. Gamboa‐Gómez,Martha Rodríguez‐Morán,Maya Orrante,Estefany Rosales-Galindo,Itzel Cisneros-Ramírez,Mariana Arce‐Quiñones,Karen Orona-Díaz,Luis E. Simental‐Mendía,Gerardo Martínez‐Aguilar
标识
DOI:10.1684/mrh.2023.0519
摘要
Clinical manifestations related to hypomagnesemia and/or deficiency of vitamin D are frequent in patients with an extended course of coronavirus disease-2019 (long COVID). To evaluate hypomagnesemia and hydroxyvitamin D deficiency in patients with long COVID. A total of 125 adults with a diagnosis of long COVID were enrolled in a cross-sectional study. Participants were allocated into a risk (hypomagnesemia and hydroxyvitamin D deficiency) or control (serum magnesium and hydroxyvitamin D within normal ranges) group. Hypomagnesemia and 25-hydroxyvitamin D deficiency were defined based on serum level ≤1.8 mg/dL and <30 ng/mL, respectively. The number of clinical manifestations of long COVID were significantly higher in the risk compared to the control group. Fatigue, memory loss, attention disorders, joint pain, anxiety, sleep disorders, myalgia, and depression, all of which are related to hypomagnesemia and/or 25-hydroxyvitamin D deficiency, were among the 10 most frequent manifestations in the risk group. The adjusted odds ratio for the association between hypomagnesemia and hydroxyvitamin D deficiency during long COVID was 3.1; 95% CI 2.3-12.4, p=0.005. Our results show that patients suffering with long COVID had a deficiency in magnesium and 25-hydroxyvitamin D which correlated with the number of associated clinical manifestations.
科研通智能强力驱动
Strongly Powered by AbleSci AI